Browse
Prediction results retrieved after performance evaluation of WHO approved 34 primers to estimate their binding affinities for 3892 SARS-CoV-2 variants.

Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used
  
BA.2.20SWon-SCTACATGCACCAGCAACTGT20502311423133F-22142.8South Korea
BA.2.20SWon-SCACCTGTGCCTGTTAAACCA20502321323194R-21965.9South Korea
BA.2.20EWon-ETTCGGAAGAGACAGGTACGTT2147.622625926279F-18253.7South Korea
BA.2.20EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
BA.2.20NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
BA.2.20NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
BA.2.73ORF1abWon-ORF1abCATGTGTGGCGGTTCACTAT20501544115460F-22753.7South Korea
BA.2.73ORF1abWon-ORF1abTGCATTAACATTGGCCGTGA20451555815539R-21175.8South Korea
BA.2.73SWon-SCTACATGCACCAGCAACTGT20502311423133F-22142.8South Korea
BA.2.73SWon-SCACCTGTGCCTGTTAAACCA20502321323194R-21965.9South Korea
BA.2.73EWon-ETTCGGAAGAGACAGGTACGTT2147.622625926279F-18253.7South Korea
BA.2.73EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
BA.2.73NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
BA.2.73NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
XDZORF1abWon-ORF1abCATGTGTGGCGGTTCACTAT20501544115460F-15341.9South Korea
XDZORF1abWon-ORF1abTGCATTAACATTGGCCGTGA20451555815539R-301.668South Korea
XDZSWon-SCTACATGCACCAGCAACTGT20502311423133F-22142.8South Korea
XDZSWon-SCACCTGTGCCTGTTAAACCA20502321323194R-21965.9South Korea
XDZEWon-ETTCGGAAGAGACAGGTACGTT2147.622625926279F-18253.7South Korea
XDZEWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
XDZNWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
XDZNWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
XEBORF1abWon-ORF1abCATGTGTGGCGGTTCACTAT20501544115460F-22753.7South Korea
XEBORF1abWon-ORF1abTGCATTAACATTGGCCGTGA20451555815539R-21175.8South Korea
XEBSWon-SCTACATGCACCAGCAACTGT20502311423133F-22142.8South Korea
XEBSWon-SCACCTGTGCCTGTTAAACCA20502321323194R-21965.9South Korea
XEBEWon-ETTCGGAAGAGACAGGTACGTT2147.622625926279F-18253.7South Korea
XEBEWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
XEBNWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
XEBNWon-NGTTGCGACTACGTGATGAGG20552884928830R-19760.5South Korea
B.1.263ORF1abWon-ORF1abCATGTGTGGCGGTTCACTAT20501544115460F-22753.7South Korea
B.1.263ORF1abWon-ORF1abTGCATTAACATTGGCCGTGA20451555815539R-21175.8South Korea
B.1.263SWon-SCTACATGCACCAGCAACTGT20502311423133F-22142.8South Korea
B.1.263SWon-SCACCTGTGCCTGTTAAACCA20502321323194R-21965.9South Korea
B.1.263EWon-ETTCGGAAGAGACAGGTACGTT2147.622625926279F-22650South Korea
B.1.263EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.359ORF1abWon-ORF1abCATGTGTGGCGGTTCACTAT20501544115460F-22753.7South Korea
B.1.359ORF1abWon-ORF1abTGCATTAACATTGGCCGTGA20451555815539R-21175.8South Korea
B.1.359SWon-SCTACATGCACCAGCAACTGT20502311423133F-22142.8South Korea
B.1.359SWon-SCACCTGTGCCTGTTAAACCA20502321323194R-21965.9South Korea
B.1.359EWon-ETTCGGAAGAGACAGGTACGTT2147.622625926279F-22650South Korea
B.1.359EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.359NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
B.1.359NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
B.1.302ORF1abWon-ORF1abCATGTGTGGCGGTTCACTAT20501544115460F-22753.7South Korea
B.1.302ORF1abWon-ORF1abTGCATTAACATTGGCCGTGA20451555815539R-21175.8South Korea
B.1.302SWon-SCTACATGCACCAGCAACTGT20502311423133F-22142.8South Korea
B.1.302SWon-SCACCTGTGCCTGTTAAACCA20502321323194R-21965.9South Korea
B.1.302EWon-ETTCGGAAGAGACAGGTACGTT2147.622625926279F-22650South Korea
B.1.302EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used